Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. - sprookjes - yvandenbroek - TriplyDB

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

http://www.wikidata.org/entity/Q37485865

about

SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells Targeting angiogenesis in gynecologic cancers EGFR/HER-targeted therapeutics in ovarian cancer Chemoresistance and targeted therapies in ovarian and endometrial cancers α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.Targeting the EGFR signaling pathway in cancer therapy.Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian Cancer NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options.Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.The status of epidermal growth factor receptor in borderline ovarian tumours.High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway.Network analysis identifies an HSP90-central hub susceptible in ovarian cancer New developments in the treatment of ovarian cancer--future perspectives.Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.Monoclonal antibodies therapies for ovarian cancer.Biomarkers for early detection of ovarian cancer.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review Targeted agents and combinations in ovarian cancer: where are we now?Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α.Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.Preferential effect of akt2-dependent signaling on the cellular viability of ovarian cancer cells in response to EGF.

P2860

Q24304872-E79DE36C-2654-477F-AB6B-97477FABF359 Q26824766-BF1B0767-E290-4EEB-A01C-6AC11424ECE7 Q26863231-744A459B-3352-412A-A029-9E346A9F09E0 Q28073246-9073770D-8430-4B3C-9E7F-8497ED176CE8 Q33709977-C205FE9E-D094-4E2A-B3BC-56CE11872198 Q33829859-D6F7FD61-13C2-46CC-82F7-1C68DAA343CF Q33960748-216556E9-8260-464B-B497-372F8C4B2E3A Q33972424-BDB77680-B181-40D8-8976-BF979CE6D2AE Q34246558-A05AD4CC-4C8C-4CE7-8414-530744B07466 Q34656901-211ECAC6-C003-4366-9B49-66F20D3CF386 Q34806737-36F6B1CF-2B8E-4696-85E6-6D5450885C4D Q35098085-9C4C5499-0951-45ED-8F85-04BBA16CE7A5 Q35390011-DBB7AA0C-FD6B-4A27-95BA-835E21105468 Q35619189-337D19EA-6DDB-4C22-BCCB-A785451E43EA Q35767493-7B1AD02D-99BD-4E6D-9B81-0B4657BFC366 Q35837949-825FE48A-97EE-4828-8D9B-5159860793AA Q35882323-E34681A6-775F-408F-BE21-A1B00A2A95CC Q36159383-923601E8-F839-4EAD-91D4-1D3A3F4B4DE8 Q36504170-A7EECB14-6B7F-48E6-8556-64197969537B Q36546449-DD3A1DE5-BC74-4EDE-B4E9-9CB751FDAD27 Q36596826-91AD50A1-CDBA-407B-B2E4-74EE461DEA06 Q36648394-74485A19-06EB-4D2F-BDC1-A07A08052915 Q36960019-1A1FC453-C830-46B3-9EA4-1DCEB218D18B Q36963030-3364A12F-D4C0-4E7B-B54A-1128A4FD8CEB Q36964290-3B4DC98F-FCF5-422D-A995-AFAC93CF060D Q36974713-48240992-6524-4975-82E9-8DA764D59805 Q37185385-385AF1C7-33B8-4732-9555-3DC596F85D66 Q37332487-B5986695-3851-4B06-87D7-957CF0194118 Q37697198-92EB681B-270E-402A-902C-1F7417AEF285 Q38078400-BE282985-609B-4F28-8A3D-ADB5B4E6CE4C Q38087982-32C375F5-DB26-4E2E-8FA0-FE6685E262EE Q38366731-9D3F2D1C-86CA-4238-B462-BEB203979D89 Q38652339-E9AC0A91-2AC7-4638-9C8A-5C5734929CB8 Q38760610-4FBF5D84-F104-42BC-B8A1-767EED66A279 Q38826628-351F90F9-2140-4DC4-A0CE-E01B589B5954 Q38965047-F6A2930F-800B-45BC-BE50-6C744433A1E2 Q39198301-41D93D7D-FCE5-4019-80C4-5BA100F9E243 Q39430345-F9EA0AE4-CDBD-4B22-B185-CFAF69A639A2 Q42335706-861A79F0-0169-4D67-AE38-AA112F84C51C Q42914388-FA8D6729-C840-417B-9059-A7E5FA94E6BF

P2860

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

http://www.wikidata.org/entity/Q37485865

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Targeting the epidermal growth ...... owledge and future challenges.

@en

Targeting the epidermal growth ...... owledge and future challenges.

@nl

type

label

Targeting the epidermal growth ...... owledge and future challenges.

@en

Targeting the epidermal growth ...... owledge and future challenges.

@nl

prefLabel

Targeting the epidermal growth ...... owledge and future challenges.

@en

Targeting the epidermal growth ...... owledge and future challenges.

@nl

P1433

Q37485865-A51F3A60-404F-4121-8E9C-D694902CBDBD

P1476

Q37485865-0DBEEB3D-C40A-4EFC-88C4-2D98E4D79269

P2093

Q37485865-0A95306E-CB11-4E2C-88E5-211E55C1A19B

Q37485865-10BFEE63-9E33-4971-8413-278D72443F6A

Q37485865-51DC05D7-5450-40FC-958B-3ABD5D8A8D2D

Q37485865-93FC9C99-11E1-44FE-B557-E0C0BEFC2568

Q37485865-AF2CCFF4-6676-4267-B5CF-39EC06EEB271

Q37485865-B7183D68-BC4D-462B-ADEF-640545A93721

P2860

Q37485865-004491B2-2369-4C3B-86EF-5F7E90374D54

Q37485865-005E8977-6D96-480D-B23B-E1C9619D24F4

Q37485865-008CADA6-7675-4A55-8977-BCDCEA9852E5

Q37485865-00C527C7-37DC-4D94-B0D2-BFD9326EC5E3

Q37485865-0129FCA1-DC6F-4A5A-98E3-1DCF49113EA3

Q37485865-01EBE7D0-A74B-400D-8D9A-674E2FE6E095

Q37485865-02D5E1A5-7459-4F0C-911F-21F253E613B9

Q37485865-03995691-6050-4E3F-8FC9-AF36F30180F0

Q37485865-047297BA-AE9A-4F67-A0F8-33A95C208EE2

Q37485865-06E7C7BA-4562-42BD-AE71-AE72D5147E66

P304

Q37485865-78775F34-ECD6-48CE-95C6-5850966A3CFA

P31

Q37485865-83F46A90-8F31-41A7-BB9C-ABFE487B615E

P356

Q37485865-B12E37F9-D600-48F0-BD53-B13FA911A75B

P478

Q37485865-AD3E376B-BA1B-4B60-904F-B18245EED835

P50

Q37485865-65274CB5-0957-4E22-A043-5740C9586CFC

P577

Q37485865-91A47959-7F86-4D38-A25F-70FAC4BAC47D

P5875

Q37485865-0AC6A27C-1150-4FE6-90FC-CE22595FA877

P698

Q37485865-37D6529F-FCDD-4153-8026-32BEED989843

P921

Q37485865-E66BD5FA-FD37-4DCE-BD19-A2E01F2F2AE9

P932

Q37485865-507484F2-EF53-49C0-8782-9E9C22FC1DF8

P356

P1433

Journal of oncology

P1476

Targeting the epidermal growth ...... nowledge and future challenges

@en

P2093

Bryan T Hennessy

http://www.w3.org/2001/XMLSchema#string

Catherine T Nguyen

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

Laura Nolden

http://www.w3.org/2001/XMLSchema#string

Mark Carey

http://www.w3.org/2001/XMLSchema#string

Mollianne J McGahren Murray

http://www.w3.org/2001/XMLSchema#string

P2860

Survival of cancer cells is maintained by EGFR independent of its kinase activity

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

Gene expression patterns in ovarian carcinomas

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Animal models of ovarian cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

P304

568938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/568938

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40786488

http://www.w3.org/2001/XMLSchema#string

P698

20037743

http://www.w3.org/2001/XMLSchema#string

P921

P932

2796463

http://www.w3.org/2001/XMLSchema#string